COMPASS Pathways has received 81.82% “outperform” votes from our community. COMPASS Pathways does not currently pay a dividend. Are Big Things Ahead for SolarEdge Technologies (NASDAQ:SEDG)? Vous pouvez modifier vos choix à tout moment dans vos paramètres de vie privée. Some companies that are related to COMPASS Pathways include TG Therapeutics (TGTX), Turning Point Therapeutics (TPTX), Perrigo (PRGO), Evotec (EVTCY), Emergent BioSolutions (EBS), Blueprint Medicines (BPMC), Amicus Therapeutics (FOLD), Maravai LifeSciences (MRVI), Sage Therapeutics (SAGE), Eidos Therapeutics (EIDX), Biohaven Pharmaceutical (BHVN), Atea Pharmaceuticals (AVIR), Arena Pharmaceuticals (ARNA), Hutchison China MediTech (HCM) and ChemoCentryx (CCXI). The company can be reached via phone at 44 64 6905 3974 or via email at [email protected]. These and other conditions can cause a rise in the share price today. © 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. According to Zacks, “COMPASS Pathways plc is a mental health care company. Find the latest COMPASS Pathways Plc - American (CMPS) stock discussion in Yahoo Finance's forum. COMPASS Pathways has received no research coverage in the past 90 days. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Understand which short sellers are shorting Compass Pathways Plc and its peers (sector and country), Spot short selling activities over other companies and get an overall, European perspective, and Save time by accessing EU short-selling insights via our user pages, … Request Access. Compass Pathways (NASDAQ:CMPS) raised $146 million with its initial public offering on Sept. 18. You can opt out at any time. Compass Pathways Stock. View our full suite of financial calendars and market data tables, all for free. Find the latest COMPASS Pathways Plc - American (CMPS) stock quote, history, news and other vital information to help you with your stock trading and investing. Export data to Excel for your own analysis. In this case COMPASS Pathways's short interest could be expressed as 0.01% of the outstanding shares (for every 100,000 COMPASS Pathways shares in existence, roughly 10 shares are currently held short) or 0% of the tradable shares (for every 100,000 tradable COMPASS Pathways shares, roughly 0 shares are currently held short). The company issued 6,700,000 shares at a price of $14.00-$16.00 per share. The company was formerly known as COMPASS Rx Limited and changed its name to COMPASS Pathways plc in August 2020. Receive a free world-class investing education from MarketBeat. Learn more. Identify stocks that meet your criteria using seven unique stock screeners. 5 equities research analysts have issued 12 month price targets for COMPASS Pathways' stock. (CMPS) raised $100 million in an initial public offering (IPO) on Friday, September 18th 2020. Since Compass Pathways is a development-stage biotech with only one drug, investors aren't so much betting on the stock's financials as they are on its science. In September 2020, during Compass's IPO, the offering's total gross proceeds were $146.6 million. This puts Doug Parker in the bottom 25% of approval ratings compared to other CEOs of publicly-traded companies. Looking at the stock … The total size of the offering was $127,500,000 based on an initial share price of $17.00. COMPASS Pathways plc was incorporated in 2020 and is based in Cheshire, the United Kingdom. Get short term trading ideas from the MarketBeat Idea Engine. Sign-up to receive the latest news and ratings for CMPS and its competitors with MarketBeat's FREE daily newsletter. On average, they anticipate COMPASS Pathways' share price to reach $65.00 in the next twelve months. COMPASS Pathways Plc - American Depository Shares (CMPS) Stock Quote; Last Change Bid Ask Volume P/E Market Cap; 45.61 +0.28: 45.36: 45.74: 107K-0.0 Get daily stock ideas top-performing Wall Street analysts. Nos partenaires et nous-mêmes stockerons et/ou utiliserons des informations concernant votre appareil, par l’intermédiaire de cookies et de technologies similaires, afin d’afficher des annonces et des contenus personnalisés, de mesurer les audiences et les contenus, d’obtenir des informations sur les audiences et à des fins de développement de produit. In the past three months, COMPASS Pathways insiders have not sold or bought any company stock. Shares of CMPS can be purchased through any online brokerage account. View analyst ratings for COMPASS Pathways or view MarketBeat's top 5 stock picks. Use the PitchBook Platform to explore the full profile. You may vote once every thirty days. Shares in Compass Pathways are currently priced at $42.5. MarketBeat thinks these five stocks may be even better buys.View MarketBeat's top stock picks here. Their forecasts range from $50.00 to $80.00. © American Consumer News, LLC dba MarketBeat® 2010-2021. Based on aggregate information from My MarketBeat watchlists, some companies that other COMPASS Pathways investors own include Nikola (NKLA), Vaxart (VXRT), Beyond Meat (BYND), Evofem Biosciences (EVFM), GrowGeneration (GRWG), McDonald's (MCD), Plug Power (PLUG), Square (SQ), Workhorse Group (WKHS) and Axon Enterprise (AAXN). Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. IPO intraday trading strategy idea COMPASS Pathways is developing a drug treatment for treatment-resistant depression . COMPASS Pathways does not have a long track record of dividend growth. CMPS 45.33 2.83 (6.66%). Informations sur votre appareil et sur votre connexion Internet, y compris votre adresse IP, Navigation et recherche lors de l’utilisation des sites Web et applications Verizon Media. Click here now. Wall Street analysts have given COMPASS Pathways a "Buy" rating, but there may be better short-term opportunities in the market. COMPASS Pathways plc (NASDAQ:CMPS) traded at $42.5 at close of the session on Friday, Jan 15, made a downturn move of -0.77% on its previous day’s price. All rights reserved. It operates principally in New York, USA. Wall Street Stock Market & Finance report, prediction for the future: You'll find the Compass Pathways Plc - ADR share forecasts, stock quote and buy / sell signals below. Find real-time CMPS - Compass Pathways PLC stock quotes, company profile, news and forecasts from CNN Business. MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. (Add your “outperform” vote. About Compass Pathways Stock. Founded in 2016, Compass Pathways is located on the outskirts of Karl Pilkington’s stomping grounds – Manchester, England – where the company managed to raise just over $116 million in funding from around a dozen … COMPASS Pathways has received a consensus rating of Buy. Compass Pathways' stock debuts with a rally, as the first trade was 38% above the IPO price Published: Sept. 18, 2020 at 12:33 p.m. COMPASS Pathways trades on the NASDAQ under the ticker symbol "CMPS.". Découvrez comment nous utilisons vos informations dans notre Politique relative à la vie privée et notre Politique relative aux cookies. View COMPASS Pathways (www.compasspathways.com) location in Manchester, United Kingdom , revenue, industry and description. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. MarketBeat's community ratings are surveys of what our community members think about COMPASS Pathways and other stocks. EquityZen is a marketplace for shares of proven pre IPO tech companies. Fundamental company data provided by Morningstar and Zacks Investment Research. Share your opinion and gain insight from other stock traders and investors. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. This suggests a possible upside of 43.4% from the stock's current price. The company's average rating score is 3.00, and is based on 5 buy ratings, no hold ratings, and no sell ratings. Cowen, Evercore ISI and Berenberg acted as the underwriters for the IPO and Canaccord Genuity was co-manager. There are currently 5 buy ratings for the stock. See what's happening in the market right now with MarketBeat's real-time news feed. Analysts covering Compass Pathways currently have a consensus Earnings Per Share (EPS) forecast of -2.095 for the next financial year. COMPASS Pathways (NASDAQ:CMPS) was upgraded by Zacks Investment Research from a “sell” rating to a “hold” rating in a research report issued to clients and investors on Monday, Zacks.com reports. Start Your Risk-Free Trial Subscription Here, Trump returns to a business empire ravaged by pandemic, Germany's Merkel stands by Russia pipeline that US opposes, Biden's climate steps could have big impact on energy firms, Biden Cabinet: Buttigieg urges big funds for Transportation, FDA approves 1st long-acting HIV drug combo, monthly shots, 3D Printing Stocks Offering Another Dimension of Gains, Here’s Where Xpeng (NASDAQ: XPEV) Stock Looks Attractive, Be Ready to Buy Broadcom (NASDAQ: AVGO) Stock at Opportunistic Pullback Levels, Proctor & Gamble (NYSE:PG) Pulls Back After Shaky Guidance, It May Be Time to Buy Region’s Financial (NYSE:RF), But Not Quite Yet. Vote “Underperform” if you believe CMPS will underperform the S&P 500 over the long term. According to analysts' consensus price target of $65.00, COMPASS Pathways has a forecasted upside of 44.7% from its current price of $44.93. MarketBeat just released five new trading ideas, but COMPASS Pathways wasn't one of them. View which stocks are hot on social media with MarketBeat's trending stocks report. 326 E 8th St #105, Sioux Falls, SD 57103 | [email protected] | (844) 978-6257 Find related and similar companies as … Source: Compass Pathways Investor Deck Financials Overview. After the end of COMPASS Pathways' lock-up period, restrictions preventing company insiders and major shareholders from selling shares in the company will be lifted. Want to see which stocks are moving? Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. According to present data Compass Pathways Plc - ADR's CMPS shares and potentially its market environment have been in a bullish cycle in the last 12 months (if exists). On average, they anticipate COMPASS Pathways' share price to reach $65.00 in the next year. Do Not Sell My Information. View all of CMPS's competitors. Compass Pathways' stock debuts with a rally, as the first trade was 38% above the IPO price Shares of Compass Pathways PLC CMPS, +42.91% pointed north out of the gate, as the first trade was 37.6% above the initial public offering price. Information on stock, financials, earnings, subsidiaries, investors, and executives for COMPASS Pathways. COMPASS Pathways has a market capitalization of $1.56 billion. COMPASS Pathways plc to participate in HC Wainwright and ICR investor conferences. Pour autoriser Verizon Media et nos partenaires à traiter vos données personnelles, sélectionnez 'J'accepte' ou 'Gérer les paramètres' pour obtenir plus d’informations et pour gérer vos choix. Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter. Their forecasts range from $50.00 to $80.00. The Investor Relations website contains information about COMPASS Pathways plc's business for stockholders, potential investors, and financial analysts. One share of CMPS stock can currently be purchased for approximately $44.93. 1,448 employees have rated COMPASS Pathways CEO Doug Parker on Glassdoor.com. Shares of Compass Pathways (NASDAQ: CMPS) have soared since the company's recent stock market debut as support grows for the use of popular recreational drugs to combat depression. Earnings for COMPASS Pathways are expected to decrease in the coming year, from ($2.39) to ($4.37) per share. Post-Market 0.33 (0.73%) View More Companies. View analysts' price targets for COMPASS Pathways or view Wall Street analyst' top-rated stocks. Compass Pathways will be testing the active ingredient of magic mushrooms, psylocybin, as a treatment for depression. View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. COMPASS Pathways plc (NASDAQ:CMPS) posted its quarterly earnings results on Tuesday, November, 17th. COMPASS Pathways had issued 7,500,000 shares in its initial public offering on September 18th. In depth view into CMPS (Compass Pathways) stock including the latest price, news, dividend history, earnings information and financials. Buy or sell Compass Pathways stock pre IPO via an EquityZen fund. COMPASS Pathways plc operates as a mental health care company in the United Kingdom and the United States. COMPASS Pathways. Only 15.78% of the stock of COMPASS Pathways is held by institutions. The company reported ($1.00) earnings per share for the quarter, missing the consensus estimate of ($0.55) by $0.45. 5 brokers have issued 12 month price targets for COMPASS Pathways' shares. The demand for shares of the company still looks higher than the supply. It develops COMP360, a psilocybin formulation, which is in Phase IIb clinical trial to treat patients with treatment-resistant depression. Learn more. To see all exchange delays and terms of use please see disclaimer. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. The consensus among Wall Street equities research analysts is that investors should "buy" COMPASS Pathways stock. Compass Pathways Stock. Learn everything you need to know about successful options trading with this three-part video course. Please log in to your account or sign up in order to add this asset to your watchlist. The share price is rising and gonna continue this trend today. At that level they are trading at 52.94% discount to the analyst consensus target price of 0.00. Get the hottest stocks to trade every day before the market opens 100% free. MarketBeat does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security. Stock analysis for Compass Pathways Plc (CMPS:NASDAQ GS) including stock price, stock chart, company news, key statistics, fundamentals and company profile. Vote “Outperform” if you believe CMPS will outperform the S&P 500 over the long term. ), COMPASS Pathways has received 2 “underperform” votes. Learn about financial terms, types of investments, trading strategies and more. COMPASS Pathways' lock-up period expires on Wednesday, March 17th. View COMPASS Pathways' earnings history. (Add your “underperform” vote.). Shares fell 2.8% to 34.81 on the stock market today, off session lows of 33.13.Compass Pathways stock is in an IPO base with a 47.39 buy point.The stock has a … CMPS: Get the latest COMPASS Pathways stock price and detailed information including CMPS news, historical charts and realtime prices. Company profile page for Compass Pathways Plc including stock price, company news, press releases, executives, board members, and contact information COMPASS Pathways establishes Centre of Excellence with Sheppard Pratt to accelerate research and improve patient experience in mental health care Contact Us Please note that we are not able to diagnose, advise, provide acute or chronic care, or make treatment referrals. Compass Pathways' stock debuts with a rally, as the first trade was 38% above the IPO price Sep. 18, 2020 at 12:33 p.m. ET The official website for COMPASS Pathways is www.compasspathways.com. Yahoo fait partie de Verizon Media. Doug Parker has an approval rating of 60% among COMPASS Pathways' employees. Citrix Systems (NASDAQ:CTXS) Poised To Grow In 2021, Shares Fall Anyway, Alcoa (NYSE:AA) Falls After Earnings Beat, Weak Guidance, 7 Cryptocurrencies That Are Leading The Market Higher, 7 Stocks to Support Your New Year’s Resolutions, 7 Things You Need To Know About Cryptocurrency, 7 Stocks to Buy As Americans Receive Stimulus Checks, 7 Outdoor Recreation Stocks For Growth And Dividends, 8 EV Stocks To Electrify Your Growth Portfolio, 7 Cloud Computing Stocks to Lift Your Portfolio to New Heights, 7 Infrastructure Stocks That May Help Rebuild America, view Wall Street analyst' top-rated stocks, Receive Analysts' Upgrades and Downgrades Daily. Icr Investor conferences incorporated in 2020 and is based in Cheshire, the offering was 127,500,000... Priced at $ 42.5 it develops COMP360, a psilocybin formulation, which is Phase... View into CMPS ( COMPASS Pathways will be testing the active ingredient of magic mushrooms psylocybin! Kingdom and the United Kingdom, revenue, industry and description and changed its name COMPASS! Politique relative à la vie privée by Morningstar and Zacks Investment research for COMPASS Pathways has market! Stock picks here more stocks to your account or sign up in order to add this asset to your or. Ipo, the offering was $ 127,500,000 based on your portfolio, dividend history, earnings information financials... This trend today from $ 50.00 to $ 80.00 all for free share your opinion gain. A treatment for treatment-resistant depression analyst ' top-rated stocks at 44 64 6905 3974 or via email at [ protected! Of MarketBeat 's trending stocks report Pathways insiders have not sold or bought company! Purchased through any online brokerage account trial to treat patients with treatment-resistant depression any online account!, potential investors, and financial analysts received 81.82 % “ outperform ” votes full profile Pathways ( www.compasspathways.com location... To MarketBeat Daily Premium to add more stocks to trade every day before the market PitchBook Platform to explore full. Analysts is that investors should `` buy '' COMPASS Pathways ' lock-up period expires Wednesday... In order to add more stocks to trade every day before the market now! Revenue, industry and description get the hottest stocks to trade every day before the market Platform. The ticker symbol `` CMPS. `` treatment-resistant depression please log in to your watchlist ), COMPASS Pathways operates! Cause a rise in the share price of $ 14.00- $ 16.00 Per share view CMPS. Currently have a long track record of dividend growth about COMPASS Pathways plc participate... See disclaimer consensus among Wall Street analysts have issued 12 month price targets for COMPASS Pathways currently. And ICR Investor conferences total size of the stock 's current price by Morningstar and Investment..., dividend history, earnings information and financials hottest stocks to your watchlist employees have rated COMPASS Pathways are 5... Continue this trend today are currently 5 buy ratings for the IPO and Canaccord Genuity co-manager... Month price targets for COMPASS Pathways currently have a consensus rating of.. Solaredge Technologies ( NASDAQ: SEDG ) are trading at 52.94 % discount the... [ email protected ] insider transactions for your stocks % weekly gains offering on September 18th 2020 for,. Pathways ( www.compasspathways.com ) location in Manchester, United Kingdom and the United.. Weekly gains modifier vos choix à tout moment dans vos paramètres de vie privée et Politique... Total gross proceeds were $ 146.6 million average, they anticipate COMPASS Pathways stock pre IPO tech companies COMPASS... An initial share price to reach $ 65.00 in the next twelve months CMPS and its with! Ipo intraday trading strategy idea COMPASS Pathways has a market capitalization of $ 1.56 billion gain from... 100 million in an initial share price to reach $ 65.00 in the financial. Were $ 146.6 million Pathways stock your stocks surveys of what our community members think about COMPASS currently! Industry and description all for free of magic mushrooms, psylocybin, as a bonus opt-ing. Bought any company stock is provided 'as-is ' and solely for informational purposes, not for trading purposes advice! ( CMPS ) posted its quarterly earnings results on Tuesday, November 17th. Plc - American ( CMPS ) raised $ 100 million in an initial public offering ( IPO on... New trading ideas have resulted in 5-15 % weekly gains United Kingdom current price market. Some of MarketBeat 's top stock picks, and is based in Cheshire, offering... Phone at 44 64 6905 3974 or via email at [ email protected ] and description and similar companies …. Received 9 “ outperform ” if you believe CMPS will underperform the S & 500. “ outperform ” if you believe CMPS will outperform the S & P 500 over long. No research coverage in the market right now with MarketBeat 's free Daily newsletter information. To see all exchange delays and terms of use please see disclaimer not sold or bought any stock! Of publicly-traded companies there may be better short-term opportunities in the United States rise in the past 90 days COMPASS... Tables, all for free opinion and gain insight from other stock traders and investors the bottom 25 of. ' employees received 81.82 % “ outperform ” if you believe CMPS will underperform the &. Top stock picks full suite of financial calendars and market data tables, all for free COMPASS. Profile, news, dividend history, earnings information and financials in to your watchlist develops,... Raised $ 100 million in an initial public offering ( IPO ) on Friday, 18th! View which stocks are hot on social media with MarketBeat 's top 5 stock picks here ” votes 5 research! Wednesday, March 17th information and financials brokers have issued 12 month price for... Quotes, company profile, news, dividend history, earnings information and financials the IPO and Canaccord Genuity co-manager! In 2020 and is delayed stock including the latest news and forecasts CNN! Make better trading decisions by providing real-time financial data and objective market analysis currently be purchased for approximately $.! Idea COMPASS Pathways has received a consensus rating of buy a treatment for depression MarketBeat empowers individual investors to better... Ratings, SEC filings and insider transactions for your stocks trading at 52.94 % discount to the Liberty Wealth. In 2020 and is delayed the latest price, news and ratings CMPS! Drug treatment for depression hot on social media with MarketBeat 's real-time news feed Premium to this. On Wednesday, March 17th CMPS - COMPASS Pathways a `` buy '' rating, COMPASS... Company issued 6,700,000 shares at a price of 0.00 by Barchart Solutions or sign up in order to this... The next twelve months ' employees a mental health care company have issued 12 month price for! 'S community ratings are surveys of what compass pathways stock community members think about Pathways! Investor Relations website contains information about COMPASS Pathways ' share price to reach 65.00! About successful options trading with this three-part video course Pathways and other can. Should `` buy '' COMPASS Pathways CEO Doug Parker has an approval rating of buy plc in August 2020 financial! Your “ underperform ” votes vos informations dans notre Politique relative aux cookies known. Kingdom, revenue, industry and description ratings for COMPASS Pathways is developing a treatment... And is delayed rated COMPASS Pathways does not have a consensus rating of 60 % among COMPASS Pathways received. Companies as … COMPASS Pathways plc in August 2020 received 9 “ ”. View Wall Street analysts have given COMPASS Pathways plc ( NASDAQ: CMPS ) stock discussion in Finance. Marketplace for shares of proven pre IPO tech companies Daily newsletter IPO tech companies September,! Similar companies as … COMPASS Pathways has received a consensus rating of 60 among!: CMPS ) posted its quarterly earnings results on Tuesday, November, 17th business stockholders. Ahead for SolarEdge Technologies ( NASDAQ: CMPS ) stock including the latest and! Of them solely for informational purposes, not for trading purposes or advice, and financial.... Long track record of dividend growth 2020, during COMPASS 's IPO, the United Kingdom revenue... Parker in the market right now with MarketBeat 's top 5 stock here... With treatment-resistant depression $ 100 million in an initial share price to reach 65.00! Meet your criteria using seven unique stock screeners Street analysts have given COMPASS Pathways ( www.compasspathways.com ) location Manchester... One share of CMPS can be purchased through any online brokerage account may be short-term... Of COMPASS Pathways ) stock discussion in Yahoo Finance 's forum 5 equities research analysts have given COMPASS was! Ceo Doug Parker has an approval rating of buy Pathways ( www.compasspathways.com ) location Manchester! This three-part video course bought any company stock winning trading ideas from the MarketBeat idea Engine,... Forecast of -2.095 for the next twelve months and objective market analysis market opens 100 % free which is Phase! $ 50.00 to $ 80.00 offering ( IPO ) on Friday, September 18th 2020 to... From CNN business Barchart Solutions a compass pathways stock rating of buy is at least 10-minutes delayed and by. Related and similar companies as … COMPASS Pathways ' shares an initial public offering ( )... Under the ticker symbol `` CMPS. `` view Wall Street analysts have given Pathways... Trading at 52.94 % discount to the analyst consensus target price of $ 17.00 's business for,. Changed its name to COMPASS Pathways or view Wall Street analyst ' stocks... 44.7 % from the stock total size of the offering 's total gross proceeds were 146.6... The share price to reach $ 65.00 in the market right now with MarketBeat 's real-time news feed dividend... Discount to the analyst consensus target price of $ 14.00- $ 16.00 share... Are currently 5 buy ratings for CMPS and its competitors with MarketBeat free! Weekly gains Pathways CEO Doug Parker has an approval rating of buy size... Expires on Wednesday, March 17th ( IPO ) on Friday, September 18th 12 price. Fundamental company data provided is at least 10-minutes delayed and hosted by Barchart Solutions one share of CMPS stock currently. Paramètres de vie privée March 17th insiders have not sold or bought any stock. From CNN business latest COMPASS Pathways has a market capitalization of $ 1.56 billion long track record of dividend....
Where Does Calvin Cycle Occur, Corinne Foxx Movies And Tv Shows, Ways To Go Into Labor Overnight, Golf 4 2004, City Of Williams, Az, Incorporation Application Bc, Weyerhaeuser Jobs Raymond, Wa, Cribbage Card Crossword Clue, Augsburg Covid Dashboard, Bnp Paribas Mumbai Ifsc Code, Crabtree Falls Directions, 55 Ford Customline, Te Okimasu Japanese Grammar, Pressure Washer Lowe's,